Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies London Healthcare Conference Transcript

Nov 16, 2022 / 10:20AM GMT
Release Date Price: $239.39 (-4.27%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

All right. We'll go ahead and get started. Good morning. Thank you for your attendance here at Jefferies London Healthcare Conference for 2022. I'm Dave Windley. I work in the U.S. healthcare research group, cover CROs and CDMOs, among some other sectors.

Very glad to -- pleased to have Charles River Laboratories here with us again. Appreciate your consistent attendance at this London Healthcare Conference. And Flavia Pease is the company's Chief Financial Officer -- Executive VP and Chief Financial Officer, having joined the company just 6 months ago.

Flavia H. Pease
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

That's right.

Questions & Answers

David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

And has been doing her deep dive into the company. So that really segues into my first question, which is about Flavia, your initial impressions and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot